Adhesion molecules like ICAM-1 on multiple myeloma cells increase the binding capacity to BMSCs and overexpression of ICAM-1 have been associated with more advanced disease and drug resistance [11–13]. Here, ICAM1 is linked to plasma cell myeloma.